Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources

Enanta Pharma (ENTA) Receives $30M Milestone from AbbVie

November 20, 2015 9:06 AM EST

Enanta Pharma (NASDAQ: ENTA) disclosed the following on Friday morning:

Enanta Pharmaceuticals, Inc. has earned a $30 million milestone payment from AbbVie following the recent price reimbursement approval in Japan of AbbVies VIEKIRAX treatment for HCV infection, which had been approved for regulatory... More

New Treasury Guidelines on Inversion May Not Apply to Allergan (AGN)/Pfizer (PFE) - Evercore ISI's Raffat

November 20, 2015 8:33 AM EST

There's lots of analyst chatter this morning on the pending Allergan (NYSE: AGN), Pfizer (NYSE: PFE) deal amid the... More